Floatz logo

Fludarabine

Sarcoma, Synovial

Hadassah Medical OrganizationSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

22 Active assets in the Sarcoma, Synovial cohort.

Asset / SponsorPhaseRating
Tazemetostat
Epizyme, Inc.
Phase 2BB
Cyclophosphamide
Zelluna Immunotherapy AS
Phase 2BB
Pembrolizumab
Valo Therapeutics Oy
Phase 2B
Cixutumumab
National Cancer Institute (NCI)
Phase 2B
Imatinib
National Cancer Institute (NCI)
Phase 2B

View all 36 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →